Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation

Seiichiro Katagiri, Mitsuru Moriyama, Seiichiro Yoshizawa & Daigo Akahane, SungGi Chi & Yosuke Minami, Seiichiro Katagiri